tradingkey.logo

Natera Inc

NTRA

162.970USD

-0.690-0.42%
終値 09/26, 16:00ET15分遅れの株価
22.15B時価総額
損失額直近12ヶ月PER

Natera Inc

162.970

-0.690-0.42%
詳細情報 企業名
企業情報
企業コードNTRA
会社名Natera Inc
上場日Jul 02, 2015
最高経営責任者「CEO」Mr. Steven Leonard (Steve) Chapman
従業員数4424
証券種類Ordinary Share
決算期末Jul 02
本社所在地13011 Mccallen Pass
都市AUSTIN
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号78753
電話番号16502499090
ウェブサイトhttps://www.natera.com/
企業コードNTRA
上場日Jul 02, 2015
最高経営責任者「CEO」Mr. Steven Leonard (Steve) Chapman
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Matthew Rabinowitz, Ph.D.
Dr. Matthew Rabinowitz, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.32M
-1.69%
Mr. Roelof Frederick Botha
Mr. Roelof Frederick Botha
Lead Independent Director
Lead Independent Director
1.23M
+0.01%
Mr. Jonathan Sheena
Mr. Jonathan Sheena
Co-Founder, Director
Co-Founder, Director
311.77K
-0.98%
Mr. Daniel A Rabinowitz
Mr. Daniel A Rabinowitz
Secretary, Chief Legal Officer
Secretary, Chief Legal Officer
151.45K
-1.05%
Mr. John Fesko
Mr. John Fesko
President, Chief Business Officer
President, Chief Business Officer
88.14K
+1.14%
Herman Rosenman, CPA
Herman Rosenman, CPA
Independent Director
Independent Director
65.67K
+0.23%
Mr. Solomon Moshkevich
Mr. Solomon Moshkevich
President - Clinical Diagnostics
President - Clinical Diagnostics
46.21K
-6.67%
Dr. Monica Bertagnolli, M.D.
Dr. Monica Bertagnolli, M.D.
Independent Director
Independent Director
6.13K
+1.79%
Mr. Steven Leonard (Steve) Chapman
Mr. Steven Leonard (Steve) Chapman
Chief Executive Officer, Director
Chief Executive Officer, Director
4.42K
-68.63%
Mr. Michael Burkes Brophy
Mr. Michael Burkes Brophy
Chief Financial Officer
Chief Financial Officer
4.36K
-53.71%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Matthew Rabinowitz, Ph.D.
Dr. Matthew Rabinowitz, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.32M
-1.69%
Mr. Roelof Frederick Botha
Mr. Roelof Frederick Botha
Lead Independent Director
Lead Independent Director
1.23M
+0.01%
Mr. Jonathan Sheena
Mr. Jonathan Sheena
Co-Founder, Director
Co-Founder, Director
311.77K
-0.98%
Mr. Daniel A Rabinowitz
Mr. Daniel A Rabinowitz
Secretary, Chief Legal Officer
Secretary, Chief Legal Officer
151.45K
-1.05%
Mr. John Fesko
Mr. John Fesko
President, Chief Business Officer
President, Chief Business Officer
88.14K
+1.14%
Herman Rosenman, CPA
Herman Rosenman, CPA
Independent Director
Independent Director
65.67K
+0.23%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Insurance carriers
472.65M
94.18%
Laboratory and other partners
20.83M
4.15%
Patients
8.35M
1.66%
地域別USD
会社名
収益
比率
United States
492.31M
98.10%
Europe, Middle East, India, Africa
6.05M
1.21%
Asia Pacific and Other
1.78M
0.36%
Americas, excluding U.S
1.69M
0.34%
事業別
地域別
事業別USD
会社名
収益
比率
Insurance carriers
472.65M
94.18%
Laboratory and other partners
20.83M
4.15%
Patients
8.35M
1.66%
株主
更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.20%
T. Rowe Price Associates, Inc.
8.79%
JP Morgan Asset Management
6.50%
BlackRock Institutional Trust Company, N.A.
4.94%
Farallon Capital Management, L.L.C.
3.51%
他の
67.06%
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.20%
T. Rowe Price Associates, Inc.
8.79%
JP Morgan Asset Management
6.50%
BlackRock Institutional Trust Company, N.A.
4.94%
Farallon Capital Management, L.L.C.
3.51%
他の
67.06%
種類
株主統計
比率
Investment Advisor
46.29%
Investment Advisor/Hedge Fund
27.68%
Hedge Fund
12.63%
Individual Investor
3.13%
Family Office
2.73%
Family Office
2.73%
Family Office
2.35%
Bank and Trust
1.98%
Research Firm
1.44%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
1137
131.96M
96.64%
-402.16K
2025Q1
1129
133.60M
97.90%
+2.21M
2024Q4
1001
128.40M
95.17%
-537.76K
2024Q3
896
125.06M
100.75%
-6.81M
2024Q2
850
125.13M
101.89%
-7.92M
2024Q1
798
124.30M
101.71%
-6.12M
2023Q4
781
119.55M
99.60%
-13.66M
2023Q3
787
122.52M
102.97%
-5.30M
2023Q2
792
116.72M
102.40%
-10.10M
2023Q1
788
115.81M
102.22%
-9.06M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
12.34M
9.04%
+53.13K
+0.43%
Mar 31, 2025
T. Rowe Price Associates, Inc.
10.43M
7.64%
+3.78M
+56.77%
Mar 31, 2025
JP Morgan Asset Management
6.39M
4.68%
+531.80K
+9.07%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
6.68M
4.89%
+212.90K
+3.29%
Mar 31, 2025
Farallon Capital Management, L.L.C.
4.55M
3.33%
+116.20K
+2.62%
Mar 31, 2025
State Street Global Advisors (US)
3.37M
2.47%
+379.58K
+12.69%
Mar 31, 2025
Duquesne Family Office LLC
3.40M
2.49%
-164.52K
-4.61%
Mar 31, 2025
Wellington Management Company, LLP
3.06M
2.24%
-180.35K
-5.57%
Mar 31, 2025
RTW Investments L.P.
2.59M
1.9%
+223.00
+0.01%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.39M
1.75%
+153.28K
+6.87%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Sep 6
更新時刻: Sat, Sep 6
銘柄名
比率
Alger Weatherbie Enduring Growth ETF
6.31%
Franklin Genomic Advancements ETF
5.47%
ARK Genomic Revolution ETF
4.61%
VanEck Biotech ETF
4.36%
Alger Mid Cap 40 ETF
3.52%
First Trust NYSE Arca Biotechnology Index Fund
3.51%
Global X Genomics & Biotechnology ETF
3.46%
TrueShares Technology, AI & Deep Learning ETF
3.3%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.29%
FT Raymond James Multicap Growth Equity ETF
2.66%
詳細を見る
Alger Weatherbie Enduring Growth ETF
比率6.31%
Franklin Genomic Advancements ETF
比率5.47%
ARK Genomic Revolution ETF
比率4.61%
VanEck Biotech ETF
比率4.36%
Alger Mid Cap 40 ETF
比率3.52%
First Trust NYSE Arca Biotechnology Index Fund
比率3.51%
Global X Genomics & Biotechnology ETF
比率3.46%
TrueShares Technology, AI & Deep Learning ETF
比率3.3%
First Trust Nasdaq Lux Digi Health Solutions ETF
比率3.29%
FT Raymond James Multicap Growth Equity ETF
比率2.66%
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI